Institution
McGill University
Education•Montreal, Quebec, Canada•
About: McGill University is a education organization based out in Montreal, Quebec, Canada. It is known for research contribution in the topics: Population & Context (language use). The organization has 72688 authors who have published 162565 publications receiving 6966523 citations. The organization is also known as: Royal institution of advanced learning & University of McGill College.
Topics: Population, Context (language use), Poison control, Health care, Cancer
Papers published on a yearly basis
Papers
More filters
•
TL;DR: In this article, the influence of the structure and composition of a firm's alliance network on its exploratory innovation was examined and the benefits of network closure and access to diverse information can coexist in a firm’s alliance network.
Abstract: This study examines the influence of the structure and composition of a firm’s alliance network on its exploratory innovation. In a longitudinal investigation of 77 telecommunications equipment manufacturers, I find the technological diversity of a firm’s alliance partners increases its exploratory innovation. I also find that network density among a firm’s alliance partners strengthens the influence of diversity. These results suggest the benefits of network closure and access to diverse information can coexist in a firm’s alliance network and the combination of the two increases exploratory innovation.
742 citations
••
TL;DR: The non-fasting ApoB/ApoA1 ratio was superior to any of the cholesterol ratios for estimation of the risk of acute myocardial infarction in all ethnic groups, in both sexes, and at all ages, and it should be introduced into worldwide clinical practice.
739 citations
••
TL;DR: Using a multistage genetic association approach comprising 7,480 affected individuals and 7,779 controls, markers in chromosomal region 8q24 associated with colorectal cancer were identified and this locus has been implicated in prostate cancer.
Abstract: Using a multistage genetic association approach comprising 7,480 affected individuals and 7,779 controls, we identified markers in chromosomal region 8q24 associated with colorectal cancer. In stage 1, we genotyped 99,632 SNPs in 1,257 affected individuals and 1,336 controls from Ontario. In stages 2-4, we performed serial replication studies using 4,024 affected individuals and 4,042 controls from Seattle, Newfoundland and Scotland. We identified one locus on chromosome 8q24 and another on 9p24 having combined odds ratios (OR) for stages 1-4 of 1.18 (trend; P = 1.41 x 10(-8)) and 1.14 (trend; P = 1.32 x 10(-5)), respectively. Additional analyses in 2,199 affected individuals and 2,401 controls from France and Europe supported the association at the 8q24 locus (OR = 1.16, trend; 95% confidence interval (c.i.): 1.07-1.26; P = 5.05 x 10(-4)). A summary across all seven studies at the 8q24 locus was highly significant (OR = 1.17, c.i.: 1.12-1.23; P = 3.16 x 10(-11)). This locus has also been implicated in prostate cancer.
739 citations
01 Jan 1995
TL;DR: This work proposed that there are two genes I and O that regulate the activity of the betagalactosidase producing genes and that the production of beta-gal is controlled by an inhibitory regulation mechanism.
Abstract: In 1965 Jacques Monod and François Jacob were awarded the Nobel prize for discovering that there are regulator genes that control the activity of other genes. They discovered this by investigating the utilization of energy sources, such as glucose, in E. coli. E. coli need glucose to live and their most common source of glucose is lactose. When lactose is present, E. coli secrete betagalactosidase enzymes that break down lactose into glucose. Betagalactosidase is secreted only when lactose is present. Jacob and Monod discovered that a set of regulator genes inhibit the genes that produce betagalactosidase until betagalactosidase is needed. They proposed that there are two genes I and O that regulate the activity of the betagalactosidase producing genes and that the production of beta-gal is controlled by an inhibitory regulation mechanism. As can be seen from Figure 1, when no lactose is present the I gene produces an inhibitor that binds to the O gene, and this prevents the betagalactosidase genes from producing betagalactosidase. When Lactose is present, the inhibitor secreted by the I gene binds to the lactose, rather than the O gene. When this happens, the betagalactosidase genes are no longer inhibited and, consequently, they produce betagalactosidase. When all the lactose is used, the inhibitor again binds to the O gene and production of betagalactosidase stops. Monod and Jacob made this discovery using various mutations where the I, O, and betagalactosidase genes were mutated. Crucially, they initially thought that genetic control was due to genes switching on, or activating, other genes. It was only after a large amount of research that they discovered that the mechanism of control was inhibition. Not only was this discovery relevant to production of betagalactosidase, but it was a general model of genetic control that transformed biological research.
738 citations
••
University of Toronto1, German Cancer Research Center2, University of Düsseldorf3, University of Pittsburgh4, Ontario Institute for Cancer Research5, Seoul National University6, University of Warsaw7, University of Lyon8, Mayo Clinic9, The Chinese University of Hong Kong10, Johns Hopkins University11, University of Alabama at Birmingham12, University of Washington13, Fred Hutchinson Cancer Research Center14, University of California, San Francisco15, McMaster University16, Hamilton Health Sciences17, Vanderbilt University18, University of Colorado Denver19, Semmelweis University20, Erasmus University Rotterdam21, University of Ulsan22, Kitasato University23, Mexican Social Security Institute24, Masaryk University25, Emory University26, University of Debrecen27, University of Naples Federico II28, Washington University in St. Louis29, McGill University30, Montreal Children's Hospital31, Virginia Commonwealth University32, Chonnam National University33, University of Queensland34, University of Calgary35, University of São Paulo36, University of Cincinnati37, University of Arkansas for Medical Sciences38, The Catholic University of America39, University of California, Los Angeles40, University of Sydney41, Kumamoto University42, Saint Louis University43, Case Western Reserve University44
TL;DR: Similarity network fusion (SNF) applied to genome-wide DNA methylation and gene expression data across 763 primary samples identifies very homogeneous clusters of patients, supporting the presence of medulloblastoma subtypes.
737 citations
Authors
Showing all 73373 results
Name | H-index | Papers | Citations |
---|---|---|---|
Karl J. Friston | 217 | 1267 | 217169 |
Yi Chen | 217 | 4342 | 293080 |
Yoshua Bengio | 202 | 1033 | 420313 |
Irving L. Weissman | 201 | 1141 | 172504 |
Mark I. McCarthy | 200 | 1028 | 187898 |
Lewis C. Cantley | 196 | 748 | 169037 |
Martin White | 196 | 2038 | 232387 |
Michael Marmot | 193 | 1147 | 170338 |
Michael A. Strauss | 185 | 1688 | 208506 |
Alan C. Evans | 183 | 866 | 134642 |
Douglas R. Green | 182 | 661 | 145944 |
David A. Weitz | 178 | 1038 | 114182 |
David L. Kaplan | 177 | 1944 | 146082 |
Hyun-Chul Kim | 176 | 4076 | 183227 |
Feng Zhang | 172 | 1278 | 181865 |